Treatment
-
More Ways to Treat Advanced Kidney CancerNew drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.
by Kendall K. Morgan
-
When Cancer’s Spread Is LimitedPeople with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.
by Kate Yandell
-
Facts and Stats
The Five Phases of Clinical ResearchNew treatments in the U.S. are scrutinized in various ways before and after they are approved by the Food and Drug Administration.
by Bradley Jones
-
Cancer Care’s Virtual RevolutionThe pandemic has made telehealth a necessity for many cancer patients. When the crisis clears, these technological tools may improve cancer care in the long term.
by Stephen Ornes
-
From the Editor-in-Chief
Cancer in Adolescents and Young AdultsPatients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.
by William G. Nelson, MD, PhD
-
Forward Look
New Therapies for Metastatic Lung CancerSeveral targeted drugs were approved in 2020 to treat the most common type of lung cancer.
by Ashley P. Taylor
-
Immunotherapy Indications WithdrawnIn recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?
by Anna Goshua
-
Patient Advocates Tune in for Precision Medicine PrimerScientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
-
Immunotherapy Options for Breast CancerTwo immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Are Liquid Biopsies Ready for the Clinic?Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
by Kendall K. Morgan
